CLINICAL_TRIALS
trial_result
· 2011-05-19
Clinical Trial Update: An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain [Phase 3]
Summary
Open-label Phase 3 trial of celecoxib in posttraumatic pain completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2011-05-19